Document is current
Any future updates will be listed below
-
Authors
Niman, Stephanie
Hardy, Jennifer
Goldfaden, Rebecca F. https://orcid.org/0000-0002-6401-4888
Reid, Jessica
Sheikh-Ali, Mae
Sutton, David
Choksi, Rushab
- License Information
-
More Information
Article History
Accepted: 10 March 2021
First Online: 26 March 2021
Declarations
:
: No sources of funding were received for the preparation of this article.
: Mae Sheikh-Ali has received a speaker honorarium from Novo Nordisk, Eli Lilly, AstraZeneca, Janssen, and Merck. David Sutton has received a speaker honorarium from Novo Nordisk, Eli Lilly, Boehringer Ingelheim, Zealand Pharma, AbbVie, Abbot, and Amarin. Stephanie Niman, Jennifer Hardy, Rebecca F. Goldfaden, Jessica Reid, and Rushab Choksi have no conflicts of interest that are directly relevant to the content of this article.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors contributed to the review. RG had the idea for the article, SN and JR performed the literature search and data analysis, and all authors drafted and/or critically revised the review. All authors read and approved the final manuscript.
